Financhill
Sell
46

CORT Quote, Financials, Valuation and Earnings

Last price:
$70.25
Seasonality move :
10.06%
Day range:
$68.92 - $72.21
52-week range:
$25.35 - $117.33
Dividend yield:
0%
P/E ratio:
61.53x
P/S ratio:
12.08x
P/B ratio:
11.08x
Volume:
1.2M
Avg. volume:
2.2M
1-year change:
181.02%
Market cap:
$7.6B
Revenue:
$675M
EPS (TTM):
$1.16

Earnings Data

Next earnings date for CORT
Jul 29
2025
Most recent earnings per share
$0.17
Beat by $0.03
(May 5/2025)
Consensus Estimate
$0.14
(May 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CORT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
07/29/2025 Q2 $199.4M -- -- $0.19 --
05/05/2025 Q1 $177.9M $157.2M $0.17 $0.14 $0.03
02/26/2025 Q4 $200.1M $181.9M $0.26 $0.42 -$0.16
10/30/2024 Q3 $172M $182.5M $0.41 $0.29 $0.12
07/29/2024 Q2 $155.2M $163.8M $0.32 $0.24 $0.08
05/01/2024 Q1 $141.2M $146.8M $0.25 $0.22 $0.03
02/15/2024 Q4 $129.3M $135.4M $0.28 $0.26 $0.03
11/01/2023 Q3 -- -- $0.28 $0.23 $0.05
08/02/2023 Q2 -- -- $0.25 $0.15 $0.10
05/03/2023 Q1 -- -- $0.14 $0.21 -$0.07
02/28/2023 Q4 -- -- $0.14 $0.28 -$0.14
11/03/2022 Q3 -- -- $0.30 $0.28 $0.02
08/03/2022 Q2 -- -- $0.24 $0.28 -$0.04
05/05/2022 Q1 -- -- $0.20 $0.31 -$0.11
02/15/2022 Q4 -- -- $0.26 $0.35 -$0.09
11/03/2021 Q3 -- -- $0.24 -- --
07/29/2021 Q2 -- -- $0.21 $0.17 $0.05
05/06/2021 Q1 -- -- $0.18 $0.19 -$0.01
02/08/2021 Q4 -- -- $0.20 $0.17 $0.03
11/03/2020 Q3 -- -- $0.17 $0.23 -$0.06
08/04/2020 Q2 -- -- $0.23 $0.21 $0.02
05/04/2020 Q1 -- -- $0.25 $0.21 $0.04
02/20/2020 Q4 -- -- $0.24 $0.26 -$0.02
11/07/2019 Q3 -- -- $0.22 $0.21 $0.01
08/01/2019 Q2 -- -- $0.25 $0.19 $0.06
05/09/2019 Q1 -- -- $0.20 $0.18 $0.02
02/25/2019 Q4 -- -- $0.24 $0.21 $0.03
11/01/2018 Q3 -- -- $0.22 $0.21 $0.01
08/09/2018 Q2 -- -- $0.20 $0.24 -$0.04
05/08/2018 Q1 -- -- $0.19 $0.18 $0.02
02/22/2018 Q4 -- -- -- -- --
11/02/2017 Q3 -- -- $0.14 $0.14 --
05/01/2017 Q1 -- -- -- $0.03 --
01/30/2017 Q4 -- -- -- $0.05 --
11/01/2016 Q3 -- -- $0.02 $0.01 $0.01
08/03/2016 Q2 -- -- $0.02 $0.01 $0.01
05/03/2016 Q1 -- -- $0.01 $0.01 --
11/05/2015 Q3 -- -- -- -- --
08/05/2015 Q2 -- -- -- -- --

Corcept Therapeutics Earnings Questions

  • How Much did Corcept Therapeutics Generate in Revenue Last Quarter?

    Corcept Therapeutics reported $157.2M worth of top line sales in its most recent quarter.

  • Did Corcept Therapeutics Beat Earnings Last Quarter?

    Corcept Therapeutics announced earnings per share of $0.17 which represents a beat of analyst forecast a $0.14 per share.

  • Is Corcept Therapeutics Profitable?

    Corcept Therapeutics reported $154.8M that represents $1.29 per share over the last quarter.

  • What is the Analyst Consensus for Corcept Therapeutics EPS Next Year?

    Corcept Therapeutics's earnings are forecast to grow from $1.23 per share to $1.41 per share next year representing an increase of 11.99%.

  • When is Corcept Therapeutics's Earnings Date?

    Corcept Therapeutics's next earnings date is July 29, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Spotify a Millionaire-Maker Stock?
Is Spotify a Millionaire-Maker Stock?

Spotify (NYSE:SPOT) may seem like an expensive proposition trading closer…

What Is a Millionaire-Maker Stock?
What Is a Millionaire-Maker Stock?

From time to time, investors will run across the term…

5 Investors to Follow Other Than Warren Buffett
5 Investors to Follow Other Than Warren Buffett

There is no doubt that Warren Buffett is one of…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Buy
63
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Buy
99
DAVE alert for May 9

Dave [DAVE] is up 9.31% over the past day.

Buy
52
QDEL alert for May 9

QuidelOrtho [QDEL] is down 0.22% over the past day.

Buy
61
TPC alert for May 9

Tutor Perini [TPC] is up 9.61% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock